Efficacy and Safety of Degarelix One Month Dosing Regimen in Korean Patients With Prostate Cancer
Status:
Completed
Trial end date:
2011-11-01
Target enrollment:
Participant gender:
Summary
This is an open-label, multi-centre single arm trial to investigate efficacy and safety of
degarelix in Korean patients with prostate cancer for bridging between CS21 trial
(NCT00295750) results.